Lineage Cell Therapeutics, Inc.

NYSE American: LCTX
Share price (2/14/25): $0.69
Market cap (2/14/25): $131 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Samuel George A. III

Broadwood Partners, L.P.

Broadwood Partners, L.P., Broadwood Capital Inc, Bradsher Neal C

News Filter

Announces Closing of Second Tranche of Previously Announced Registered Direct Offering

Announces Pricing of Up to $66 Million Registered Direct Offering

Reports Third Quarter 2024 Financial Results and Provides Business Update

Reports Second Quarter 2024 Financial Results and Provides Business Update

Change in Certifying Accountant, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness